Biotechnology Services

Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch. Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are…

The U.S. stepped up its efforts to get Mexico to ease its restrictions on genetically modified corn, after more than a year of high-level discussions between the countries failed to resolve the dispute.  The U.S. stepped up its efforts to get Mexico to ease its restrictions on genetically modified corn, after more than a year of high-level discussions between the countries failed to resolve the dispute.  FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an…

Biogen and Eisai’s Leqembi is up for full approval this summer. Biogen and Eisai’s Leqembi is up for full approval this summer. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please…

Shareholders selected one of the activist investor’s picks, who will replace on the board a director who had served as Illumina’s chairman. Shareholders selected one of the activist investor’s picks, who will replace on the board a director who had served as Illumina’s chairman. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong…

HealthJustices rule unanimously that Amgen patents relating to its cholesterol drug Repatha shouldn’t have been granted HealthJustices rule unanimously that Amgen patents relating to its cholesterol drug Repatha shouldn’t have been granted FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials…

ShareListen(2 min) ShareListen(2 min) FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

The stock awards that Elon Musk got for running Tesla lost nearly $10 billion in value last year. Stock declines erased $237 million in compensation for Expedia’s boss and roughly $149 million for Amazon.com Chief Executive Andy Jassy.What's NewsSee MoreWhat's News The stock awards that Elon Musk got for running Tesla lost nearly $10 billion in value last year. Stock declines erased $237 million in compensation for Expedia’s boss and roughly $149 million for Amazon.com Chief Executive Andy Jassy.What's NewsSee…

Moderna Inc.’s cancer vaccine helped prevent relapse for melanoma patients, results from a midstage trial showed, demonstrating progress in the pursuit of shots to ward off cancer by jump-starting the immune system.  About 79% of high-risk melanoma patients who got Moderna’s personalized vaccine and Merck & Co.’s immunotherapy Keytruda were alive and cancer-free at 18 months, compared with about 62% of patients who received immunotherapy alone, researchers said Sunday. The 157-person trial…

The Federal Trade Commission warned approximately 670 companies of the penalties they could face if they mislead consumers with unsubstantiated product claims, part of a continuing effort to re-establish the agency’s authority to penalize brands that engage in deceptive marketing practices. The warnings follow a December update to the FTC’s guidance on advertising health-related products that emphasized the need for concrete substantiation for claims. The new warnings aren’t limited to…

San Diego-based Illumina was ordered to unwind its already completed acquisition. Photo: MIKE BLAKE/REUTERS…